Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (10334)	6/3/1999 11:11:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Just to think about the concept that other parents with qualifing children refused to enter the trial and survived. 79/260 = 30% none would have refused 79/270 = 29% 10 refused 79/280 = 28% 79/290 = 27% 30 refused Interesting to me anyway. Shows the 62 are usefulf for thiniking about mortality.

To: Cacaito who wrote (10334)	6/4/1999 12:16:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

Xoma I.R. told me, "In general, unblinding is done once only on the final data set, rather than piecemeal." I asked in general what is done. I did not ask what is being done in this specific trial. Even so I accept that it probably is all done at once. Wonder why XOMA has become so cagey about the number of accruals for the Trauma trial. I always urge that they release this on a more regular basis. I can no longer tell if they are on track nor correct anyone when they refer to parabolic rise.